NURS FPX 8045 Assessment 3 Differentiate a QI/PI Project from a Research Study
Student name
University
NURS-FPX8045
Professor’s Name
Submission Date
Differentiate a QI/PI Project from a Research Study
(M) To characterize the disparity between the examined studies and the Quality Improvement/Performance Improvement (QI/PI) projects on account of the Mayo Center Health Framework about the MRSA outbreaks. The goal of a QI/PI project is to advance the insurance and the greatness of patients’ upkeep inside the tireless healthcare framework using certain strategies.
(E) For instance, to address MRSA cases, a QI/PI project may have measures like enhanced hand cleanliness, bettering environmental cleaning, and better medication management (Haque et al., 2020).
The treatments are planned to affect patients’ care and results immediately. They are practical recommendations that can be easily carried out in the workplace. This is the case as checked by Popovich et al. (2023) in their work where seeing the need to shape a special MRSA surveillance team can assist in the early identification of the cases and diminish the overall rate.
(A) The researchers can expand their knowledge into the hereditary mechanisms of medication resistance or the dynamics of MRSA cases to study MRSA issues in more detail.
MRSА research projects incorporate frameworks such as genome sequencing, population frames, and clinical investigations; their effects add to the accumulation of logical information and illuminate strong evidence-based strategies for combating MRSA outbreaks (Sherry et al., 2022).
(L) Clearly, QI/PI projects concentration to change the healthcare framework immediately while research concentrates on concentration to increase information to battle MRSA attacks from now on.
References
Haque, M., McKimm, J., Sartelli, M., Dhingra, S., Labricciosa, F. M., Islam, S., Jahan, D., Nusrat, T., Chowdhury, T. S., Coccolini, F., Iskandar, K., Catena, F., & Charan, J. (2020). Strategies to prevent healthcare-associated infections: A narrative overview. Risk Management and Healthcare Policy, 13(1), 1765–1780.
https://doi.org/10.2147/RMHP.S269315
Popovich, K. J., Aureden, K., Ham, D. C., Harris, A. D., Hessels, A. J., Huang, S. S., Maragakis, L. L., Milstone, A. M., Moody, J., Yokoe, D., & Calfee, D. P. (2023). SHEA/IDSA/APIC Practice Recommendation: Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute-care hospitals: 2022 update. Infection Control & Hospital Epidemiology, 44(7), 1–29.
https://doi.org/10.1017/ice.2023.102
Sherry, N. L., Gorrie, C. L., Kwong, J. C., Higgs, C., Stuart, R. L., Marshall, C., Ballard, S. A., Sait, M., Korman, T. M., Slavin, M. A., Lee, R. S., Graham, M., Leroi, M., Worth, L. J., Chan, H. T., Seemann, T., Grayson, M. L., & Howden, B. P. (2022). Multi-site implementation of whole genome sequencing for hospital infection control: A prospective genomic epidemiological analysis. The Lancet Regional Health – Western Pacific, 23.
